Comparison

AnticoagEvaluator vs IVUSAID

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

AnticoagEvaluator

This medical app assists healthcare professionals in making informed decisions regarding antithrombotic therapy for patients with non-valvular atrial fibrillation. It calculates patient risk factors, provides guideline-driven therapy recommendations, and helps optimize anticoagulant dosages.

Highlights
  • Calculate renal function and stroke/bleed risk
  • Review ACC/AHA/HRS guideline therapy
  • Generate individualized antithrombotic risk
  • Optimize DOAC dosages
  • Based on SPARC Tool
Features
Read full description

Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator. Use the app to: • Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed • Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention • Generate individualized risk for antithrombotic therapy options based on individual clinical trials. • Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics. This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com

About

IVUSAID

This free educational app teaches medical professionals how to use intravascular ultrasound (IVUS) for PCI guidance. It features interactive lessons, image interpretation tools, and complex case studies to overcome barriers to IVUS adoption.

Highlights
  • IVUS principles and image acquisition
  • Image interpretation with videos and descriptions
  • Complex coronary case studies
  • Interactive quiz section with explanations
  • PCI guidance for stent sizing and optimization
Features
Read full description

The IVUSAID App is a free educational mobile application which has been developed to teach medical professionals how to use intravascular ultrasound (IVUS) for PCI guidance based on the current guidelines using our extensive experience and large database of complex coronary cases. Despite the growing body of evidence for clinical benefits of IVUS-guided PCI, IVUS remains underutilized in much of the world including the United States. Challenges in image interpretation and education are among the barriers to widespread adoption of IVUS in everyday clinical practice. Mount Sinai Heart is a global leader within the field of interventional cardiology as well as mobile apps development. The myriad of cases and pathology which are seen in The Mount Sinai Cardiac Catheterization Laboratory make it the perfect center to educate medical professionals within this field. The Key Concepts section of IVUSAID describes principles of IVUS, image acquisition, and concepts of ultrasound behavior in various tissues. The Image Interpretation section of the app has dozens of representative cross-sectional images, videos, and descriptions of plaque types, stent apposition and expansion, artifacts, and more. A short video for each type of lesion or artifact and post-stent findings, in addition to an annotated representative cross section aims to overcome a major limitation of any article or book on IVUS which present a static image, since the actual IVUS pullback is dynamic. Twenty-one complex coronary cases demonstrate IVUS guidance in a variety of patient presentations and lesions including ACS, LM bifurcation, severely calcified lesions and calcified nodules, spontaneous coronary artery dissection, and malapposed stents as well as how IVUS was used to inform treatment decisions. An extensive quiz section helps deliver educational content in a more interactive format where answers are accompanied by detailed explanations and references. We hope that IVUSAID will help techs, fellows, and early-career physicians incorporate IVUS in their daily practice for stent sizing, post-stent optimization, and identification of appropriate treatment strategies.

Screenshots

AnticoagEvaluator4 screens
IVUSAID4 screens

Verdict

The call

The clearest difference is rating: IVUSAID at 5.0 against AnticoagEvaluator's 2.3. AnticoagEvaluator's advantage is ads (none vs listed) and update cadence (every 7 months vs every 18 months). On price, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ad data · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ad data · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

IVUSAID holds the better App Store score, 5.0 against 2.3. Both are backed by a comparable volume of ratings — 3 and 1 respectively.

UpkeepUpdate frequency

AnticoagEvaluator ships an update every 7 months, IVUSAID every 18 months. The most recent releases landed on November 20, 2026 and November 14, 2026 respectively.

Scorecard6 real differences · 4 level
AnticoagEvaluator versus IVUSAID: the parameters behind the verdict, then further details
ParameterAnticoagEvaluatorIVUSAID
PriceFreeFree
Rating2.3 (3 ratings)5.0 (1 ratings) — better
Positive reviews30.0% of reviews—
Number of ratings3 — better1
Update frequencyEvery 7 months — betterEvery 18 months
Ad dataNo — betterYes
In-app purchasesNoNo
MonetizationFree — betterAd-supported
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS11.0 — better15.0
Further details — not scored
Size25 MB80 MB
Age rating17+17+
DeveloperAmerican College of CardiologyCardiology Apps LLC

Customer experience

AnticoagEvaluator

All ratings3 ratings
Positive33.3%
Neutral0.0%
Negative66.7%
Written reviews10 reviews
Positive30.0%
Neutral0.0%
Negative70.0%

IVUSAID

All ratings1 ratings
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

AnticoagEvaluator

No in-app purchases

None

IVUSAID

No in-app purchases

Questions

Is AnticoagEvaluator free?
AnticoagEvaluator is free to download, with no in-app purchases.
Is IVUSAID free?
IVUSAID is free to download, with no in-app purchases.
Which has better reviews, AnticoagEvaluator or IVUSAID?
IVUSAID is rated higher. AnticoagEvaluator averages 2.3 out of 5 from 3 ratings, while IVUSAID averages 5.0 from 1 ratings.
Do AnticoagEvaluator or IVUSAID have ads?
The App Store privacy details of IVUSAID list data used for advertising; those of AnticoagEvaluator do not.
Which is updated more often, AnticoagEvaluator or IVUSAID?
AnticoagEvaluator ships an update every 7 months, and IVUSAID every 18 months. Most recently, AnticoagEvaluator was updated on November 20, 2026 and IVUSAID on November 14, 2026.

Other comparisons